Erez Minka, DO
MOHS-Micrographic Surgery · Wichita Falls, TXNPI 1679993265
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,863 of the $2,143 with a category attached, or 86.9%. It is spread thinly across 25 manufacturers, the largest accounting for just 13.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $653 and has fallen 84.0% since, to $105 in 2025.
Across 102 payments — averaging $21.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$280
- AbbVie$247
- Sanofi$210
- Galderma Laboratories, L.p.$149
- Lilly USA, LLC$145
- Sun Pharmaceutical Industries Inc.$133
- plus $979 from 19 others
What the payments were for
- Food & beverage$1,86387%
- Education$28013%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 1 | $280 |
| AbbVie | 17 | $247 |
| Sanofi | 10 | $210 |
| Galderma Laboratories, L.p. | 10 | $149 |
| Lilly USA, LLC | 7 | $145 |
| Sun Pharmaceutical Industries Inc. | 6 | $133 |
| UCB, Inc. | 8 | $126 |
| Regeneron Healthcare Solutions, Inc. | 5 | $114 |
| Johnson & Johnson | 5 | $103 |
| Mayne Pharma Commercial LLC | 5 | $100 |
| Pfizer | 5 | $98 |
| Novartis | 4 | $57 |
| Smith+Nephew | 2 | $54 |
| E.r. Squibb & Sons, L.L.C. | 3 | $50 |
| Amgen | 2 | $45 |
| Revance Therapeutics, Inc. | 1 | $34 |
| Kerecis Limited | 1 | $31 |
| Sebela Pharmaceuticals Inc. | 2 | $30 |
| Biofrontera Inc. | 2 | $26 |
| Almirall LLC | 1 | $24 |
| Verrica Pharmaceuticals Inc. | 1 | $22 |
| Incyte Corporation | 1 | $21 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $16 |
| Dermavant Sciences, Inc. | 1 | $16 |
| Convatec Inc. | 1 | $13 |
How this compares
$2,143 in reported general payments places this provider in the 55th percentile of 109 mohs-micrographic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OtezlaApremilast | 12 | $55,957 |
| Dupixent SyringeDupilumab | 12 | $42,307 |
| Clobetasol Propionate | 209 | $7,461 |
| Minocycline Hcl | 381 | $4,188 |
| Triamcinolone Acetonide | 172 | $3,416 |
| Fluocinolone Acetonide | 74 | $3,365 |
| Fluorouracil | 42 | $2,637 |
| Metronidazole | 33 | $1,758 |
| Ketoconazole | 108 | $1,643 |
| Doxycycline Hyclate | 135 | $1,576 |
| Gentamicin Sulfate | 56 | $1,354 |
| Hydrocortisone | 52 | $461 |
| Clindamycin Phosphate | 11 | $356 |
| ValacyclovirValacyclovir Hcl | 20 | $336 |
| Mupirocin | 36 | $257 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AmgenOtezla | $45 | $55,95712 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 109 mohs-micrographic surgery providers in Texas.
Other mohs-micrographic surgery in Wichita Falls
- Mamad BagheriWichita Falls$5K
- Aaron FarbergRockwall$1.5M
- Suneel ChilukuriBellaire$288K
- Ryan O QuinnSan Antonio$167K
- Paul FriedmanHouston$131K
- Brent SpencerFrisco$45K
- Julie CroleyThe Woodlands$30K
- Kayla McNieceBellaire$13K
- Hubert ChodkiewiczCedar Park$13K
- Meredith OrsethCedar Hill$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.